Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
(TORNTPHARM)
XNSE:TORNTPHARM, XBOM:TORNTPHARM
Torrent Pharmaceuticals Ltd Q4FY24; 56% rise in Profits
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Torrent Pharmaceuticals Ltd Q3FY24; 52% rise in Profits
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Torrent Pharmaceuticals Ltd Q2 FY24 Earnings Conference Call Insights
Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q2 FY24 Earnings Concall Revenue Growth Across Key Markets India business revenue grew 18% year-on-year;
Torrent Pharmaceuticals Ltd Q2FY24; 24% rise in Profits
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Torrent Pharmaceuticals Ltd Q1FY24; 7% rise in Profits
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Torrent Pharmaceuticals Ltd Q4FY23 revenue grows by 17%
Torrent Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹2,452 Crore, up from ₹ Crore year on year depicting a growth
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY23 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q4 FY23 Earnings Concall dated May. 30, 2023 Corporate Participants: Sudhir Menon — Executive Director, (Finance) and Chief Financial
Torrent pharma Q3FY23 net profit rises by 14 percent
Torrent Pharma reported that its consolidated net profit increased by 14 per cent to INR 283 crore in the third quarter ended
Torrent Pharmaceuticals Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q3 FY23 Earnings Concall Management Update: [00:05:39] TORNTPHARM said the company expects to file about
Torrent Pharmaceutical reports 14% rise in its net profit for Q3FY23
Torrent Pharma on Wednesday said its consolidated net profit increased by 14 per cent to INR 283 crore in the third quarter
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q3 FY23 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q3 FY23 Earnings Concall dated Jan. 25, 2023 Corporate Participants: Sudhir Menon -- Executive Director, (Finance) and Chief Financial
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q2 FY23 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Sudhir Menon -- Chief Financial Officer & Executive